


Ask a doctor about a prescription for Lernidum
Lercanidipine Hydrochloride
Lernidum Contains the Active Substance Lercanidipine Hydrochloride, which Belongs to a Group of so-called Calcium Antagonists (Dihydropyridine Derivatives) - Medications that Lower Blood Pressure. This Medication is Used to Treat High Blood Pressure (Hypertension) in Adults.
Treatment of Mild to Moderate Essential Hypertension in Adults.
This Medication Must not be Used During Pregnancy or Breastfeeding (See Section: "Pregnancy, Breastfeeding and Fertility").
Before Taking Lernidum, Discuss with Your Doctor or Pharmacist if You:
If You are Pregnant (or Think You May be Pregnant) or Breastfeeding, Inform Your Doctor (See Section: "Pregnancy, Breastfeeding and Fertility").
This Medication Must not be Used in Children and Adolescents Under 18 Years of Age, as the Safety and Efficacy of Lercanidipine have not been Established.
Tell Your Doctor or Pharmacist About all Medications You are Currently Taking or Have Recently Taken, as well as any Medications You Plan to Take, Especially if You are Taking:
Tell Your DoctorBefore Taking the Medication.
During Treatment, Do not:
If You are Pregnant or Breastfeeding, Think You May be Pregnant or Plan to Have a Child, Do not Take Lernidum.
Women of Childbearing Age Should Use Effective Contraception While Taking Lernidum. If You Become Pregnant During Treatment, Inform Your Doctor Immediately, who will Decide on Further Treatment.
Lernidum Does not Have a Significant Effect on the Ability to Drive or Operate Machines, but Undesirable Effects Such as Dizziness, Weakness, Fatigue and Rarely - Drowsiness May Occur. Be Cautious and Do not Drive or Operate Machines Until You Know Your Individual Reaction to the Medication.
Lernidum, 10 mg Contains 0.928 mg of Sodium in Each Tablet.
The Medication Contains Less than 1 mmol (23 mg) of Sodium per Tablet, i.e. it is Considered "Sodium-Free".
Lernidum, 20 mg Contains 1.437 mg of Sodium in Each Tablet.
The Medication Contains Less than 1 mmol (23 mg) of Sodium per Tablet, i.e. it is Considered "Sodium-Free".
Always Take this Medication Exactly as Your Doctor has Told You. If You are Not Sure, Consult Your Doctor or Pharmacist.
The Recommended Dose is 10 mg (1 Tablet) Once a Day, Taken at the Same Time Every Day, Preferably in the Morning, at Least 15 Minutes Before Breakfast.
If Necessary, Your Doctor May Increase the Dose to 20 mg (1 Tablet) Once a Day.
Swallow the Tablets Whole with Water.
The Score Line on the Lernidum, 10 mg Tablet is Only to Facilitate Breaking the Tablet to Make it Easier to Swallow, and not to Divide it into Equal Doses.
The Lernidum, 20 mg Tablet can be Divided into Equal Doses.
No Dose Adjustment is Necessary, but Caution Should be Exercised at the Beginning of Treatment.
Caution Should be Exercised at the Beginning of Treatment and When Increasing the Dose to 20 mg Once a Day.
This Medication Must not be Used in Children and Adolescents Under 18 Years of Age.
Do not Take a Higher Dose than Recommended.
In Case of Overdose or if You have Taken More than the Recommended Dose, Seek Medical Attention Immediately and, if Possible, Bring the Remaining Tablets and/or the Medication Packaging with You.
Taking a Higher Dose than Recommended May Cause Excessive Lowering of Blood Pressure and Irregular or Rapid Heartbeat, which can also Lead to Loss of Consciousness.
If You Miss a Dose, Skip the Missed Dose and Take the Next Tablet at the Usual Time the Next Day. Do not Take a Double Dose to Make up for the Missed Dose.
If You Stop Taking the Medication, Your Blood Pressure May Increase Again. Before Stopping the Medication, Consult Your Doctor.
If You have any Further Questions on the Use of this Medication, Consult Your Doctor or Pharmacist.
Like all Medications, Lernidum can Cause Undesirable Effects, although not Everybody gets them.
You Should ImmediatelyStop Taking this Medication and Consult Your Doctor or Go to the Emergency Department of the Nearest Hospital if You Experience:
In Patients with Angina Pectoris, the Use of Medications from the Same Group as Lernidum may Increase the Frequency, Duration or Severity of Pain Attacks. Isolated Cases of Heart Attack have been Observed.
Common (May Occur in Less than 1 in 10 People):
Uncommon (May Occur in Less than 1 in 100 People):
Rare (May Occur in Less than 1 in 1000 People):
Frequency Not Known (Frequency Cannot be Estimated from the Available Data):
If You Experience any Undesirable Effects, Including those not Mentioned in this Package Leaflet, Inform Your Doctor, Pharmacist or Nurse. Undesirable Effects can be Reported Directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw
Phone: +48 22 49 21 301;
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Undesirable Effects can also be Reported to the Marketing Authorization Holder.
Reporting Undesirable Effects will Help to Gather More Information on the Safety of the Medication.
Keep the Medication Out of Sight and Reach of Children.
Do not Use this Medication After the Expiration Date Stated on the Carton and Blister Pack after EXP. The Expiration Date Refers to the Last Day of the Month.
Lernidum, 10 mg
Store in the Original Packaging to Protect from Light.
Lernidum, 20 mg
Store at a Temperature Below 30°C.
Store in the Original Packaging to Protect from Light.
Lot - Means Batch Number.
Medications Should not be Disposed of via Wastewater or Household Waste. Ask Your Pharmacist How to Dispose of Medications that are No Longer Needed. This will Help Protect the Environment.
Lernidum, 10 mg
The Active Substance is Lercanidipine Hydrochloride.
Each Film-Coated Tablet Contains 10 mg of Lercanidipine Hydrochloride, which Corresponds to 9.4 mg of Lercanidipine.
Other Ingredients are:
Tablet Core: Corn Starch, Sodium Carboxymethylcellulose (Type A), Colloidal Silica, Microcrystalline Cellulose, Poloxamer 188, Sodium Stearyl Fumarate, Macrogol 6000.
Tablet Coating: Hypromellose 6cps, Macrogol 6000, Yellow Iron Oxide (E 172), Titanium Dioxide (E 171).
Lernidum, 20 mg
The Active Substance is Lercanidipine Hydrochloride.
Each Film-Coated Tablet Contains 20 mg of Lercanidipine Hydrochloride, which Corresponds to 18.8 mg of Lercanidipine.
Other Ingredients are:
Tablet Core: Microcrystalline Cellulose, Corn Starch, Sodium Carboxymethylcellulose (Type A), Colloidal Silica, Povidone K-30, Sodium Stearyl Fumarate.
Tablet Coating: Hypromellose 6cps, Macrogol 6000, Red Iron Oxide (E 172), Titanium Dioxide (E 171).
Lernidum, 10 mg is a Yellow, Round, Biconvex Film-Coated Tablet with a Score Line on One Side, Smooth on the Other Side, with Dimensions of Approximately 6.5 mm x 3.3 mm.
Lernidum, 10 mg is Packaged in Blisters. One Package Contains: 10, 14, 28 or 56 Film-Coated Tablets in a Carton.
Lernidum, 20 mg is a Pink, Round, Biconvex Film-Coated Tablet with a Score Line on One Side, Smooth on the Other Side, with Dimensions of Approximately 8.5 mm x 4.0 mm.
Lernidum, 20 mg is Packaged in Blisters. One Package Contains: 10, 14, 28 or 56 Film-Coated Tablets in a Carton.
Not all Pack Sizes may be Marketed.
Aflofarm Farmacja Polska Sp. z o.o.
Partyzancka Street 133/151,
95-200 Pabianice
Phone: (42) 22-53-100
Aflofarm Farmacja Polska Sp. z o.o.
Szkolna Street 31,
95-054 Ksawerów
Poland
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Lernidum – subject to medical assessment and local rules.